The enigmatic syndrome of metastatic cancer of unknown primary (CUP) site has frustrated physicians and patients for decades. There has been debate whether CUP is a single biologically distinct cancer ...
Doctors are testing a new three-drug treatment that may help patients with cancer whose original source cannot be found.
Patients with unfavorable cancer of unknown primary (CUP) lived significantly longer without disease progression when they received molecularly guided therapy (MGT) instead of chemotherapy, according ...
Carcinomas are cancers that start in epithelial cells, which line organs, skin, and blood vessels. Carcinoma of unknown primary (CUP) means doctors can detect this cancer, but they cannot identify ...
This study is led by Dr. Zhiguo Luo (Department of Medical Oncology, Fudan University Shanghai Cancer Center). Cancer of unknown primary (CUP), a set of histologically confirmed metastases that cannot ...
A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease This retrospective analysis ...
Site-specific therapy guided by gene-expressing profiling (GEP) could improve outcomes for patients with previously untreated cancers of unknown primary (CUP), Chinese researchers suggested. In their ...
MUNICH — More than two thirds of patients with cancer of unknown primary (CUP) have mutations detectable on circulating tumor DNA (ct-DNA) testing, or so-called liquid biopsy. For these patients, ...
A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types in patients with cancers of unknown primary (CUP), according to research ...
SAN DIEGO – Researchers from Kindai University in Japan have developed a machine learning model that accurately predicts the origin of diverse cancer types in patients with cancers of unknown primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results